Avantor Q1 net sales fall 5.6% to $1.68B; net income down 50% to $60M

Avantor, Inc.

2024-Q1 EPS reported $0.09 revenue$1,679,800,000

Net sales $1.68B, -5.6% YoY; organic decline 6.3%. Net income $60M vs $121.5M prior year.
Diluted GAAP EPS $0.09, adjusted EPS $0.22; Adjusted EBITDA $283M.
Laboratory Solutions organic sales -4.5%; Bioscience Production organic -10.0%.
Operating cash flow $142M, free cash flow $107M; FY2024 guidance reaffirmed.
Adjusted net leverage 4.0x as of March 31, 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Avantor, Inc. reported first fiscal quarter ended March 31, 2024 results: revenue $1.68 billion, net income $60.4 million, EPS $0.09. Guidance reaffirmed.

Period: first fiscal quarter ended March 31, 2024
Revenue: $1.68 billion
Net income: $60.4 million
EPS: $0.09
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Act of 1933, except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Avantor® Reports First Quarter 2024 Results • Net sales of $1.68 billion, decrease of 5.6%; organic decline of 6.3% • Net income of $60 million; Adjusted EBITDA of $283 million • Diluted GAAP EPS of $0.09; adjusted EPS of $0.22 • Operating cash flow

View on SEC.gov

316 earnings releases filed in the last 30 days. Browse all earnings releases →

Avantor, Inc. filing history →

Source: SEC EDGAR

accession 0001722482-24-000100

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.